Pier Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Pier Capital’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-362,328	Closed	-$9.26M	–	132
2018 Q2	$9.26M	Buy	+362,328	New	+$8.45M	1.27%	9
2016 Q1	–	Sell	-113,379	Closed	-$3.88M	–	132
2015 Q4	$3.88M	Sell	113,379 -111,072	-49%	-$3.47M	0.67%	84
2015 Q3	$6.45M	Buy	224,451 +36,872	+20%	+$1.58M	1.05%	38
2015 Q2	$8.39M	Buy	+187,579	New	+$7.06M	1.21%	7

Other funds holding DPLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Pier Capital's DPLO Position: Q3 2018 in Review

Pier Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 362,328 shares — an estimated $9.26M sold.

Pier Capital first reported a position in DPLO in Q2 2015 and held it in 4 quarters. The position peaked at $9.26M in Q2 2018. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

Pier Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
Pier Capital sold 362,328 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $9.26M.
Pier Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 4 quarters.
Pier Capital's DIPLOMAT PHARMACY, INC. position peaked at $9.26M in Q2 2018.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Pier Capital's 13F filing for Q3 2018, filed 14 Nov 2018.